Versantis
VerifiedA Swiss pharmaceutical company developing new generations of liver disease medicines and diagnostics.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$72—108m (Dealroom.co estimates Sep 2019.)
Company register number CH-020.3.041.748-6
Zurich Canton of Zürich (HQ)